tiprankstipranks

Pediatrix Medical price target raised to $18 from $14 at Jefferies

Jefferies analyst Jack Slevin raised the firm’s price target on Pediatrix Medical (MD) to $18 from $14 and keeps a Buy rating on the shares. The company “showed strength on all fronts” in Q3, including EBITDA, free cash flow and same-store trends, the analyst tells investors. Despite the move higher, the stock “remains cheap given a best-in-class FCF profile & tangible earnings improvement opportunities,” the analyst argues in a post-earnings note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue